Tech Company Financing Transactions
Cohera Medical Funding Round
On 12/19/2011, Cohera Medical raised $25 million in Series C funding from Kern Whelan Capital and private investors.
Transaction Overview
Company Name
Announced On
12/19/2011
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Kern Whelan Capital (John Kern)
Proceeds Purpose
The company will use the funds to expand adoption in Germany and additional European markets for its lead product, TissuGlu® Surgical Adhesive. The funds will also be used to support the clinical trials for TissuGlu in the United States.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
227 Fayetteville St. 900
Raleigh, NC 27601
USA
Raleigh, NC 27601
USA
Phone
Website
Email Address
Overview
Cohera Medical, Inc. is aimed at fulfilling the market demand for a strong, safe tissue adhesive to improve the wound closure process by positioning tissues for optimal healing while minimizing fluid accumulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Daly
Chief Scientific Officer
Dottie Clower
Vice President
Mart Pearson
VP - Finance
Justin Alexander
VP - General Counsel
Chad Coberly
VP - Sales
John Wyatt
Browse more venture capital transactions:
Prev: 12/19/2011: BestVendor venture capital transaction
Next: 12/19/2011: Cloudant venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs